Prevention of thromboxane A2 receptor-mediated pulmonary hypertension by a nonpeptide angiotensin II type 1 receptor antagonist.

Bertolino, F

Prevention of thromboxane A2 receptor-mediated pulmonary hypertension by a nonpeptide angiotensin II type 1 receptor antagonist. [electronic resource] - The Journal of pharmacology and experimental therapeutics Feb 1994 - 747-52 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

0022-3565


15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid
Angiotensin II--antagonists & inhibitors
Angiotensin Receptor Antagonists
Animals
Antihypertensive Agents--pharmacology
Biphenyl Compounds--pharmacology
Blood Pressure--drug effects
Bridged Bicyclo Compounds, Heterocyclic
Enalapril--pharmacology
Fatty Acids, Unsaturated
Hematocrit
Hydrazines--pharmacology
Hypertension, Pulmonary--etiology
Imidazoles--pharmacology
Losartan
Male
Prostaglandin Endoperoxides, Synthetic--pharmacology
Rats
Rats, Sprague-Dawley
Receptors, Thromboxane--physiology
Tetrazoles--pharmacology
Thromboxane A2--analogs & derivatives